Systemic dysfunction and plasticity of the immune macroenvironment in cancer models-Reference-Cited by-同舟云学术

Systemic dysfunction and plasticity of the immune macroenvironment in cancer models

Published:2020-05-25 Issue:7 Volume:26 Page:1125-1134
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Allen Breanna M.^ORCID,Hiam Kamir J.^ORCID,Burnett Cassandra E.,Venida Anthony,DeBarge Rachel,Tenvooren Iliana,Marquez Diana M.^ORCID,Cho Nam Woo,Carmi Yaron^ORCID,Spitzer Matthew H.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | NIH Office of the Director

U.S. Department of Health & Human Services | NIH | National Cancer Institute

UCSF Program for Breakthrough Biomedical Research, Parker Institute for Cancer Immunotherapy

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-020-0892-6.pdf

Reference60 articles.

1. Philip, M. et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature 545, 452–456 (2017).

2. Spitzer, M. H. et al. Systemic immunity is required for effective cancer immunotherapy. Cell 168, 487–502 (2017).

3. Fransen, M. F. et al. Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy. JCI Insight 3, 1–7 (2018).

4. Tang, H. et al. PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression. J. Clin. Invest. 128, 580–588 (2018).

5. Chamoto, K. et al. Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity. PNAS 114, E761–E770 (2017).

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entering the TiME machine: How age-related changes in the tumor immune microenvironment impact melanoma progression and therapy response;Pharmacology & Therapeutics;2024-10

2. Amivantamab efficacy in wild-type EGFR NSCLC tumors correlates with levels of ligand expression;npj Precision Oncology;2024-09-06

3. Dysregulation of systemic immunity and its clinical application in gastric cancer;Frontiers in Immunology;2024-09-05

4. Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals the reduction of CD169+ macrophages by metastatic breast cancers;eBioMedicine;2024-09

5. An approach for developing a blood-based screening panel for lung cancer based on clonal hematopoietic mutations;PLOS ONE;2024-08-22